Laurus Labs in my pov, is like a spawner business. making new fields and succeeding.
ARV API → Formulations → CDMO → bio and also to non arv api’s and non-arv formulations.
developing to such extent is also a great thing.
Now with animal and agro, you get new things to go for. why so? because sooner or later the cdmo will get demerged. (self-reliant subsidiary by xyz date was clearly written in investor presentation and that’s the need of that business for ip protection and assurity)
In the recent interview dr. chava himself said that time for agro takes less time for approval compared to human.
and in my view animal will also be less compared to humans. companion animal will be a high margin business(hope so unless they go for generics here).
dis: invested and biased
Subscribe To Our Free Newsletter |